Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Oncology|January 31, 2026
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective studyYuri Takamatsu, Yoshiya Horimoto, Yasuo Miyoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2022
[Eight Cases of Catheter Fracture in Internal Jugular Vein Ports for Breast Cancer Chemotherapy]Kei Hasegawa, Aya Kitano, Yuri Takamatsu, et al.
Transplantation Proceedings|July 7, 2021
Transplantation in Hepatocellular Carcinoma: Observational Multivariate Analysis of Survival and Recurrence Factors in 414 PatientsFernanda Yuri Takamatsu, Adriano Miziara Gonzalez, Gustavo Piloto Sá, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 15, 2021
[Satisfaction and Difficulties in the Daily Life of Patients with Breast Cancer Who Received Chemotherapy through a Central Venous Port System-A Questionnaire Survey]Kei Hasegawa, Yoko Takano, Megumi Takada, et al.
Studies in Health Technology and Informatics|August 8, 2025
Development of an Automated Classification System for Medication-Related Incident Factors: A Practical Approach to Enhancing Patient Safety ManagementYuri Takamatsu, Sayaka Ebara, Hayato Kizaki, et al.
World Journal of Oncology|October 29, 2020
Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II TrialTakanori Kin, Shoichiro Ohtani, Reina Maeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[A Case of Breast Carcinoma with Cartilaginous Differentiation and Distant Metastasis with Complete Response to Post-Operative Chemotherapy]Shiho Sakaguchi, Kei Hasegawa, Yuri Takamatsu, et al.
Pageof 1